Chemotherapy Resistance and Sensitivity Testing in Lung Tumors

Completed

Conditions studied: Lung Cancer

In brief

The purpose of this study is to screen chemotherapy drugs currently used to treat lung cancer and determine the most effective treatment based on results of chemo sensitivity testing on the patients own cancer cells in the laboratory. The results of this screening will not influence the patients treatment.

Key facts

Study ID

NCT01570855

Run by

Marshall University

People needed

45

Starts

2011-10-01

Expected to finish

2015-12-01

Last updated by the study team

2016-04-27

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• suspected or confirmed diagnosis of lung cancer
• undergoing a fine needle aspiration, core biopsy, or excisional biopsy for diagnosis.
• Chemotherapy must be clinically indicated for treatment of the patient's qualifying disease
• Patient must be at least 18 years of age
• Patient must have signed an IRB approved informed consent form for the data collection study prior to entry of data into the enrollment form in the database.

You may not qualify if…

• Patient pathology shows benign pathology for sample submitted
• Patient is not indicated to receive chemotherapy for their disease

Where it is running

• Cabell Huntington Hospital — Huntington, West Virginia, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.